Related Experiment Video

Updated: Aug 5, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Single-chain antibodies: A therapeutic modality for cancer gene therapy (review)

Charles A Leath1, Joanne T Douglas, David T Curiel

  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, AL, USA.

International Journal of Oncology
|March 11, 2004
PubMed

Insights

Cancer gene therapy utilizes single-chain variable fragments (scFv) to target molecular processes in carcinogenesis. This approach enhances gene transfer efficiency and exploits molecular differences between normal and malignant cells for novel cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Gene therapy is evolving beyond inherited metabolic disorders to treat complex diseases like cancer.
  • Cancer gene therapy leverages molecular distinctions between normal and malignant cells.
  • Current strategies involve oncolytic viruses, targeted gene delivery, and enhanced viral vectors.

Purpose of the Study:

  • To explore the role of single-chain variable fragments (scFv) in cancer gene therapy.
  • To discuss how scFv target molecular processes driving carcinogenesis.
  • To highlight scFv's potential in improving gene transfer efficiency for cancer treatment.

Main Methods:

  • Review of current gene therapy approaches for cancer.
  • Focus on the application of single-chain variable fragments (scFv).
  • Analysis of scFv in targeting carcinogenesis-associated molecular pathways.

Main Results:

  • Single-chain variable fragments (scFv) show promise in targeting cancer-specific molecular processes.
  • scFv can enhance the efficiency of gene transfer in cancer gene therapy.
  • The use of scFv represents a significant advancement in molecular targeting for malignancy.

Conclusions:

  • Single-chain variable fragments (scFv) are a valuable tool in advancing cancer gene therapy.
  • Targeting molecular processes with scFv offers a novel strategy for combating cancer.
  • Further research into scFv applications could lead to more effective cancer treatments.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.